Go Deep
Korsana Biosciences, Inc.
Korsana Biosciences, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -41,392 | -4.8 | -45.12 | 0.01 | 3,187.16 |
| Oct 2026 | -40,433 | -4.6 | -43.41 | 0.01 | 3,066.87 |
| Oct 2026 | -39,701 | -4.4 | -42.11 | 0.01 | 2,978.18 |
| Oct 2026 | -39,162 | -4.4 | -41.60 | 0.01 | 2,942.15 |
| Oct 2026 | -40,302 | -4.6 | -43.63 | 0.01 | 3,077.70 |
| Oct 2026 | -40,974 | -4.7 | -44.82 | 0.01 | 3,155.49 |
| Oct 2026 | -39,374 | -4.4 | -41.98 | 0.01 | 2,967.63 |
Korsana Biosciences, Inc. Quarterly Results
| Line Item | Jun 2026 |
|---|---|
| EPS | -3.4 |
Korsana Biosciences, Inc. Revenue & Profit: Last 2 Years
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -35,642,000.0 | -88,000.0 |
| EPS | — | -0.0 |
Korsana Biosciences, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 154,596,000.0 | 10,108,000.0 |
| Total Liabilities | 188,564,000.0 | 10,042,000.0 |
| Total Equity | -33,968,000.0 | 66,000.0 |
Owes vs Owns
Korsana Biosciences, Inc. owed $1.22 for every $1 it owned in Dec 2025, up from $0.99 in Dec 2024.
| Period | Dec 2025 | Dec 2024 |
|---|---|---|
| Owes vs Owns | 1.22× | 0.99× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Korsana Biosciences, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 99.7%
How it's funded — Dec 2025
Other liabilities 99.9%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 154.1 | 10.1 |
| Receivables | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 0.5 | 0.0 |
| Liabilities & equity | ||
| Short-term debt | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 |
| Payables | 0.2 | 0.1 |
| Other liabilities | 188.4 | 10.0 |
| Shareholders' equity | -34.0 | 0.1 |
| Net tangible assets | -34.0 | 0.1 |
Korsana Biosciences, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Operating Activities | -22,406,000.0 | 44,000.0 |
| Financing Activities | 166,433,000.0 | 10,064,000.0 |